We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:
Medicine & public health

Search Results

Showing 1-20 of 928 results

  1. Terapia del carcinoma corticosurrenalico dopo fallimento del mitotane

    Mitotane is the only approved drug in the management of adrenocortical carcinoma (ACC). Mitotane can be administered in the adjuvant setting in...

    Salvatore Grisanti, Valentina Cremaschi, Alfredo Berruti in L'Endocrinologo
    Article Open access 19 September 2023

  2. Mitotane

    in Reactions Weekly
    Article 08 June 2024

  3. Mitotane

    in Reactions Weekly
    Article 13 April 2024

  4. Mitotane

    in Reactions Weekly
    Article 30 March 2024

  5. Mitotane

    in Reactions Weekly
    Article 13 April 2024

  6. Mitotane

    in Reactions Weekly
    Article 06 April 2024

  7. Mitotane

    in Reactions Weekly
    Article 08 June 2024

  8. Mitotane

    in Reactions Weekly
    Article 11 November 2023

  13. Mitotane/Simvastatin

    in Reactions Weekly
    Article 23 December 2023

  14. Mitotane

    in Reactions Weekly
    Article 04 March 2023

  15. EDP-mitotane in children: reassuring evidence of reversible side-effects and neurotoxicity

    Adrenocortical carcinoma affects one in 5 million children each year. Since prognosis for children older than 4 years is limited, clinicians often...

    Rebecca V. Steenaard, Marieke Rutjens, ... Harm R. Haak in Discover Oncology
    Article Open access 18 April 2022

  18. Mitotane

    in Reactions Weekly
    Article 07 January 2023

  19. Mitotane

    in Reactions Weekly
    Article 25 February 2023
Did you find what you were looking for? Share feedback.